SCHEMBL18847237

SCHEMBL18847237

c1ccc(-c2cn3ccc(-c4cccc(-c5nc6ccccc6c6c5ccc5c7ccccc7oc56)c4)cc3n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR9 Q9NR96 1/20 0.39
▸ SCD O00767 1/20 0.37
▸ PDE10A Q9Y233 2/20 0.36
▸ PLK4 O00444 1/20 0.36
▸ JAK2 O60674 1/20 0.36
▸ RET P07949 1/20 0.36
▸ PIM1 P11309 1/20 0.36
▸ FGFR1 P11362 1/20 0.36
▸ FLT1 P17948 1/20 0.36
▸ KDR P35968 1/20 0.36
▸ FLT3 P36888 1/20 0.36
▸ PIM3 Q86V86 1/20 0.36
▸ ALK Q9UM73 1/20 0.36
▸ BACE1 P56817 2/20 0.35
▸ BACE2 Q9Y5Z0 2/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ NPC1 O15118 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ PKM P14618 1/20 0.34
▸ KLF5 Q13887 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18846934 0.94 SCD (0.41) TLR9SCDPDE10APLK4JAK2
SCHEMBL18847234 0.91 BACE1 (0.42) BACE1BACE2NPC1KDM4EPKM
SCHEMBL18847491 0.90 BACE1 (0.46) BACE1BACE2HDAC1NPC1KDM4E
SCHEMBL18847515 0.89 ALDH1A3 (0.47) NPC1KDM4EPKMALDH1A1RAB9A
SCHEMBL18847067 0.87 BACE1 (0.45) BACE1BACE2NPC1KDM4EPKM
SCHEMBL18201085 0.84 TLR9 (0.44) TLR9SCDPDE10APLK4JAK2
SCHEMBL18847243 0.81 DHODH (0.37) PDE10AFLT3KDM4EPKMMAPT
SCHEMBL18846855 0.81 ALDH1A3 (0.53) NPC1KDM4EPKMALDH1A1POLB
SCHEMBL17915391 0.80 TLR9 (0.46) TLR9SCDPDE10APLK4JAK2
SCHEMBL18847158 0.80 HPGD (0.38) PDE10AFLT3KDM4EPKMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10446765-B2 Heterocyclic compound and organic light emitting element using same HEESUNG MATERIAL LTD. (KR) 2019-10-15 — — US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 — — US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME CRY1, CRY2, PER2 TLR9 4593/4885SCD 2134/4885PDE10A 3022/4885
US-10446765-B2 Heterocyclic compound and organic light emitting element using same CRY1, CRY2, PER2 TLR9 4593/4885SCD 2134/4885PDE10A 3022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback